Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-5-7
|
pubmed:abstractText |
The pharmacokinetics of co-trimoxazole in serum, bronchoalveolar lavage-fluid (BAL-fluid) and alveolar macrophages (AM) of guinea pigs receiving sulphamethoxazole (100 mg/kg) and trimethoprim (20 mg/kg) were studied. HPLC showed that peak co-trimoxazole levels were obtained in serum at 30 min, in BAL-fluid at 1 h and in AM at 3 h. A comparison between mean concentrations in serum, BAL-fluid and AM showed a six-fold higher concentration of trimethoprim in cells than in serum, but only 0.25-fold of sulphamethoxazole. The BAL-fluid/serum ratio was four to ten times higher for trimethoprim than for sulphamethoxazole (0.6-to-one-fold). Sulphamethoxazole/trimethoprim ratios (30 min, 1 and 3 h) were lower in BAL-fluid (4.9 +/- 0.5) and in AM (1.4 +/- 0.5) than in serum (30.7 +/- 1.6). The influence of co-trimoxazole in vitro on microbicidal capacities (superoxide anion and hydrogen peroxide generations), immunoregulation (production of interleukin 1) and pro-inflammatory agent production (tumour necrosis factor) of guinea pigs' AM was also studied. No significant effect of co-trimoxazole on superoxide anion and hydrogen peroxide generations, or on interleukin 1 and TNF production, was demonstrable.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxides,
http://linkedlifedata.com/resource/pubmed/chemical/Trimethoprim-Sulfamethoxazole...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
791-802
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1964447-Animals,
pubmed-meshheading:1964447-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:1964447-Chromatography, High Pressure Liquid,
pubmed-meshheading:1964447-Guinea Pigs,
pubmed-meshheading:1964447-Hydrogen Peroxide,
pubmed-meshheading:1964447-Immunity,
pubmed-meshheading:1964447-Interleukin-1,
pubmed-meshheading:1964447-Kinetics,
pubmed-meshheading:1964447-Macrophages,
pubmed-meshheading:1964447-Male,
pubmed-meshheading:1964447-Pneumonia,
pubmed-meshheading:1964447-Pulmonary Alveoli,
pubmed-meshheading:1964447-Superoxides,
pubmed-meshheading:1964447-Trimethoprim-Sulfamethoxazole Combination,
pubmed-meshheading:1964447-Tumor Necrosis Factor-alpha
|
pubmed:year |
1990
|
pubmed:articleTitle |
The penetration of co-trimoxazole into alveolar macrophages and its effect on inflammatory and immunoregulatory functions.
|
pubmed:affiliation |
Laboratoire de Pathologie Respiratoire Expérimentale et de Pollution Atmosphérique, Institut Pasteur, Lille, France.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|